#drug resistance

Extensive Drug Resistance Has Become Rare Among People With HIV

Why Adherence Is Important

Traffic light with green light illuminated

What Is Drug Resistance?

Extensive Drug Resistance Has Become Rare Among People With HIV

Why Adherence Is Important

What Is Drug Resistance?

POZ Poll: How many times have you switched your HIV treatment?

Switching to Dolutegravir and Lamivudine Works Well Despite Resistance Mutations

Using two instead of three or four drugs could potentially lead to cost savings in the billions.

Emergency Departments Can Facilitate Linkage to HIV Care

Providing antiretroviral starter packs for selected patients who test HIV positive is feasible and safe.

Biktarvy Plus Pifeltro Is an Option for People With Multidrug-Resistant HIV

The all-oral regimen maintained viral suppression in people with resistance to multiple antiretrovirals.

DoxyPEP STI Prevention Works Well for Gay Men—But Maybe Not for Women

Doxycycline after sex reduces the risk of gonorrhea, chlamydia and syphilis for gay men, and it does not appear to drive resistance.

Understanding Your Lab Work (Blood Tests)

Does Cannabis Use Impair Treatment Adherence?

People with HIV who recently used marijuana were twice as likely to miss taking their meds.

What You Need to Know About HIV Drug Resistance

Taking medications consistently is the best way to avoid resistance mutations.

Progress on Long-Acting HIV Treatment

Long-acting antiretrovirals are the future of HIV treatment, and new meds on the horizon could improve convenience and adherence.

Lenacapavir Shows Continued Promise for People With Drug-Resistant HIV

The long-acting HIV capsid inhibitor worked well for harder-to-treat groups, such as those with a low CD4 count.

FDA OKs Faster Administration Method for Trogarzo

The long-acting monoclonal antibody, approved for people with highly resistant HIV, can now be administered in 30 seconds.

Long-Acting Lenacapavir Shows Continued Promise

The injectable antiretroviral could potentially be given once every six months for HIV treatment or prevention.

Switching HIV Treatment

HIV Treatment Adherence

Dolutegravir Trumps Other HIV Meds in Cutting Viral Load—Even With Missed Doses

Compared to other common HIV treatments, dolutegravir-based regimens maintained viral suppression even without perfect adherence.

Twice-Yearly Lenacapavir Works Well for People with Highly Resistant HIV

The novel HIV capsid inhibitor also shows promise for previously untreated people.

#drug resistance

Extensive Drug Resistance Has Become Rare Among People With HIV

Why Adherence Is Important

What Is Drug Resistance?

Extensive Drug Resistance Has Become Rare Among People With HIV

Why Adherence Is Important

What Is Drug Resistance?

POZ Poll: How many times have you switched your HIV treatment?

Switching to Dolutegravir and Lamivudine Works Well Despite Resistance Mutations

Emergency Departments Can Facilitate Linkage to HIV Care

Biktarvy Plus Pifeltro Is an Option for People With Multidrug-Resistant HIV

DoxyPEP STI Prevention Works Well for Gay Men—But Maybe Not for Women

Understanding Your Lab Work (Blood Tests)

Does Cannabis Use Impair Treatment Adherence?

What You Need to Know About HIV Drug Resistance

Progress on Long-Acting HIV Treatment

Lenacapavir Shows Continued Promise for People With Drug-Resistant HIV

FDA OKs Faster Administration Method for Trogarzo

Long-Acting Lenacapavir Shows Continued Promise

Switching HIV Treatment

HIV Treatment Adherence

Dolutegravir Trumps Other HIV Meds in Cutting Viral Load—Even With Missed Doses

Twice-Yearly Lenacapavir Works Well for People with Highly Resistant HIV

Ask POZ

Science News